Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UroGen Pharma (URGN) Revenue: 2016-2024

Historic Revenue for UroGen Pharma (URGN) over the last 9 years, with Dec 2024 value amounting to $90.4 million.

  • UroGen Pharma's Revenue rose 9.04% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.5 million, marking a year-over-year increase of 8.00%. This contributed to the annual value of $90.4 million for FY2024, which is 9.29% up from last year.
  • UroGen Pharma's Revenue amounted to $90.4 million in FY2024, which was up 9.29% from $82.7 million recorded in FY2023.
  • UroGen Pharma's 5-year Revenue high stood at $90.4 million for FY2024, and its period low was $11.8 million during FY2020.
  • Moreover, its 3-year median value for Revenue was $82.7 million (2023), whereas its average is $79.2 million.
  • Data for UroGen Pharma's Revenue shows a peak YoY soared of 65,450.00% (in 2020) over the last 5 years.
  • UroGen Pharma's Revenue (Yearly) stood at $11.8 million in 2020, then skyrocketed by 307.17% to $48.0 million in 2021, then soared by 33.96% to $64.4 million in 2022, then grew by 28.52% to $82.7 million in 2023, then grew by 9.29% to $90.4 million in 2024.